MP

Meenakshi Pandey

Active Director Director DIN 09171083
DIN 09171083 First appointment May 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2021
Shareholding value •••• Premium profile

About Meenakshi Pandey

Data last updated:

Meenakshi Pandey is a Director at Perky Biotech Private Limited (since 2021). The company operates in Healthcare. Perky Biotech Private Limited reported revenue of ₹5,000 (FY 2025).

DIN 09171083
Primary Designation Director
Industry Healthcare
First Appointment 12 May 2021
Oldest Company Age 5 yrs
Largest company Perky Biotech Private Limited · ₹5,000 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Perky Biotech Private Limited U33110UR2021PTC012392
Director12 May 20212021₹5,000 (FY 2025)Active

Board colleagues of Meenakshi Pandey

NameDINCompanyDesignation
Ranjana09171084Perky Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Perky Biotech Private Limited
Premium access

Shareholding and investment profile for Meenakshi Pandey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Meenakshi Pandey

Meenakshi Pandey currently holds 1 directorship: Perky Biotech Private Limited (Director, since 12 May 2021, revenue ₹5,000 (FY 2025)).

Meenakshi Pandey was first appointed on 12 May 2021 as Director at Perky Biotech Private Limited.

The current boards of Meenakshi Pandey's companies include Ranjana (Perky Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available